Around the world, it is considered that 2.5 billion people are infected or have been infected by hepatitis B virus (HBV), that is to say 1/3 of the world's population. 

​

Natural History of HBV infection is variable, from an asymptomatic carrier status developing spontaneously to recovery, to a chronical hepatitis B, which can progress into cirrhosis and hepatocellular carcinoma.

About 240 million people are suffering from chronic hepatitis and from 0.5 to 1 million people are dying each year because of the infection.

​

​

 

 

 

GENERIC HBV Charge Virale test is a quantification tool for HBV viral load in infected patients under treatment or not.

The test relies on two main technical stages:

 

1. Extraction of plasma Viral DNA by automated method.

2. Real-time PCR amplification of extracted DNA and detection by TaqMan technology.

 

Features:

 

• Target region: S gene

• Detection limit: 95 IU/mL for a 250 µL sample

• Linearity: 125 to 1.10   IU/mL

• Duration: 3 hours (extraction + amplification)

• Type of sample: human plasma collected from EDTA

​